Efficacy and Safety of Mini-Dose Glucagon for Treatment of Nonsevere Hypoglycemia in Adults With Type 1 Diabetes.

@article{Haymond2017EfficacyAS,
  title={Efficacy and Safety of Mini-Dose Glucagon for Treatment of Nonsevere Hypoglycemia in Adults With Type 1 Diabetes.},
  author={Morey W Haymond and Stephanie N DuBose and Michael R. Rickels and Howard A. Wolpert and V N Shah and Jennifer L Sherr and Ruth S. Weinstock and Shivani Agarwal and Alandra S Verdejo and Martin J. Cummins and Brett Newswanger and Roy W Beck},
  journal={The Journal of clinical endocrinology and metabolism},
  year={2017},
  volume={102 8},
  pages={2994-3001}
}
Context Standard treatment of hypoglycemia is oral carbohydrate, but it often results in hyperglycemia and entails extra caloric intake. Objective To evaluate low-dose glucagon to treat mild hypoglycemia in ambulatory adults with type 1 diabetes (T1D). Design Randomized crossover trial (two 3-week periods). Setting Five U.S. diabetes clinics… CONTINUE READING